Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 4
2003 4
2004 3
2005 7
2006 7
2007 1
2009 1
2010 3
2011 1
2012 1
2013 1
2015 1
2016 4
2017 5
2018 3
2019 6
2020 1
2021 2
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Crowned dens syndrome.
Sato T, Hagiwara K, Sasaki M, Matsuno H, Akiyama O. Sato T, et al. Among authors: matsuno h. Intern Med. 2005 Feb;44(2):160. doi: 10.2169/internalmedicine.44.160. Intern Med. 2005. PMID: 15750282 Free article. No abstract available.
Six-month safety and effectiveness of tofacitinib in patients with rheumatoid arthritis in Japan: Interim analysis of post-marketing surveillance.
Kuwana M, Sugiyama N, Momohara S, Atsumi T, Takei S, Tamura N, Harigai M, Fujii T, Matsuno H, Takeuchi T, Yamamoto K, Takasaki Y, Tanigawa M, Endo Y, Hirose T, Morishima Y, Yoshii N, Mimori T, Takagi M. Kuwana M, et al. Among authors: matsuno h. Mod Rheumatol. 2024 Feb 26;34(2):272-286. doi: 10.1093/mr/road063. Mod Rheumatol. 2024. PMID: 37405710
[SCID-HuRAg mouse].
Matsuno H. Matsuno H. Nihon Rinsho. 2005 Jan;63 Suppl 1:59-67. Nihon Rinsho. 2005. PMID: 15799319 Review. Japanese. No abstract available.
A nationwide questionnaire survey on the prevalence of ankylosing spondylitis and non-radiographic axial spondyloarthritis in Japan.
Matsubara Y, Nakamura Y, Tamura N, Kameda H, Otomo K, Kishimoto M, Kadono Y, Tsuji S, Atsumi T, Matsuno H, Takagi M, Kobayashi S, Fujio K, Nishimoto N, Okamoto N, Nakajima A, Matsui K, Yamamura M, Nakashima Y, Kawakami A, Mori M, Tomita T. Matsubara Y, et al. Among authors: matsuno h. Mod Rheumatol. 2022 Aug 20;32(5):960-967. doi: 10.1093/mr/roab096. Mod Rheumatol. 2022. PMID: 34755187
Comparison of the efficacy and safety of LBAL, a candidate adalimumab biosimilar, and adalimumab reference product in patients with active rheumatoid arthritis inadequately responding to methotrexate: a 52-week phase III randomised study.
Matsuno H, Kang YM, Okada M, Lee SI, Park SH, Sheen DH, Sato M, Hagino A, Lee J, Shin S, Song YW. Matsuno H, et al. Clin Exp Rheumatol. 2022 May;40(5):1025-1033. doi: 10.55563/clinexprheumatol/cyudn8. Epub 2021 Jul 7. Clin Exp Rheumatol. 2022. PMID: 34251303 Clinical Trial.
51 results